[144] Intuitive Surgical Inc. SEC Filing

Rhea-AI Filing Summary

On 24 July 2025, Earlyworks Co., Ltd. (ELWS) convened its seventh Ordinary General Meeting in Tokyo. Holders of 9,727,270 votes—about 96 % of the shares eligible as of 30 Apr 2025—were represented.

• Resolution One: Approval of the fiscal-year 2024/25 financial statements (1 May 2024 – 30 Apr 2025) passed with 9,659,055 votes for and 68,215 against, equating to roughly 99.3 % support.
• Resolution Two: Election of four directors was approved with 9,623,002 votes for and 104,268 against, or about 98.9 % support.

The filing contains no additional financial figures, guidance, or strategic announcements. Given the routine nature of the matters and the overwhelming shareholder backing, the disclosure is chiefly procedural and carries limited immediate investment impact.

Insights

Corporate Governance Expert

TL;DR: Routine AGM items passed with ~99% support; neutral investment impact.

Both the financial-statement approval and director slate received near-unanimous votes, indicating solid shareholder confidence and no apparent governance controversy. However, because the filing lacks financial performance data or strategic resolutions, it does not alter the company’s risk profile or valuation drivers. I classify the event as governance housekeeping rather than a catalyst for the share price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4500	2216160.00	358476506	07/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/25/2025	Stock Option Exercise	ISSUER			4500	07/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)